Wenjun Ouyang

8PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2019
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells.

Aeryon Kim, Chia-Jung Han, Ian Driver

|Apr 26, 2019
Inflammatory Bowel Disease Susceptibility Gene C1ORF106 Regulates Intestinal Epithelial Permeability.

Paolo Manzanillo, Maria Mouchess, Naruhisa Ota

|Feb 17, 2019
Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes.

Vladimir Ramirez-Carrozzi, Naruhisa Ota, Arivazhagan Sambandam

|Jun 28, 2018
TRIMming TGF-β signals in Th17 cells.

Aaron S Rapaport, Wenjun Ouyang

Pageof 2